S4545 Systemic Amyloidosis With an Unusual Presentation as a Localized Jejunal Ulcer

Introduction: Systemic amyloidosis is characterized by the deposition of misfolded extracellular protein fibrils in various organs. The annual incidence of AL amyloidosis is approximately 9.7-14 cases per 1 million-person years. Localized jejunal involvement is a rather rare manifestation of the gastrointestinal manifestations of systemic amyloidosis. Case Description/Methods: A 69-year-old woman with prior medical history of gastric bypass, prior tobacco use and hypertension who had been suffering with malaise, 40-pound weight loss, nausea and solid dysphagia × 3 months and presented to the emergency department with hypotension. Initial labs showed normocytic anemia and mild acute kidney injury. Computed tomography scan of abdomen showed type III paraoesophageal hiatal hernia. Esophagogastroduodenoscopy demonstrated a punched-out ulceration ∼5 mm in size and multiple biopsies were sent. She was discharged with recommendations for outpatient surgical repair and prescribed a proton pump inhibitor and sucralfate. Biopsy results unexpectedly came back positive for AL type amyloidosis with Congo red staining and BM biopsy revealed 15% plasma cell population. Plans for surgical hernia repair were canceled. Cardiology referral revealed LVH + LA enlargement and elevated proBNP and she was diagnosed with diastolic HF. PET scan showed increased uptake in the tongue, likely due to macroglossia. She continued to have decreased glomerular filtration rate consistent with stage IIIb chronic kidney disease. Patient was started on chemotherapy with Dara-CyborD. Two months after her initial presentation, she developed acute watery diarrhea for 2 days, became hypotensive and was admitted to the intensive care unit with septic shock secondary to E. coli bacteremia likely due to translocation. Patient was discharged in stable condition after treatment with IV antibiotics. She is currently doing well and has resumed her chemotherapy regimen cycles. Discussion: Ours was a case of a localized jejunal ulcer as the first manifestation of systemic amyloidosis with cardiac, renal and gastrointestinal (GI) involvement. While Cowen et al estimates that GI involvement is seen in 3%-8% of amyloidosis patients, jejunal involvement remains exceptionally rare with only a few documented cases in literature. We also hypothesized that her large hiatal hernia may have been the result of amyloid fibril deposition in the smooth muscle of the gastric wall leading to structural weakening. Our case also shows the benefit of collecting biopsies from multiple GI sites as jejunal biopsy enabled us to have an earlier diagnosis of amyloidosis and start curative treatment timely.

Publication Details

Journal
The American Journal of Gastroenterology
Published
2025-10-01
DOI
https://doi.org/10.14309/01.ajg.0001145640.40426.1b
Primary Topic
Amyloidosis: Diagnosis, Treatment, Outcomes
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

S4545 Systemic Amyloidosis With an Unusual Presentation as a Localized Jejunal Ulcer

The American Journal of Gastroenterology
Amyloidosis: Diagnosis, Treatment, Outcomes
article

S4545 Systemic Amyloidosis With an Unusual Presentation as a Localized Jejunal Ulcer

article en

Abstract

Introduction: Systemic amyloidosis is characterized by the deposition of misfolded extracellular protein fibrils in various organs. The annual incidence of AL amyloidosis is approximately 9.7-14 cases per 1 million-person years. Localized jejunal involvement is a rather rare manifestation of the gastrointestinal manifestations of systemic amyloidosis. Case Description/Methods: A 69-year-old woman with prior medical history of gastric bypass, prior tobacco use and hypertension who had been suffering with malaise, 40-pound weight loss, nausea and solid dysphagia × 3 months and presented to the emergency department with hypotension. Initial labs showed normocytic anemia and mild acute kidney injury. Computed tomography scan of abdomen showed type III paraoesophageal hiatal hernia. Esophagogastroduodenoscopy demonstrated a punched-out ulceration ∼5 mm in size and multiple biopsies were sent. She was discharged with recommendations for outpatient surgical repair and prescribed a proton pump inhibitor and sucralfate. Biopsy results unexpectedly came back positive for AL type amyloidosis with Congo red staining and BM biopsy revealed 15% plasma cell population. Plans for surgical hernia repair were canceled. Cardiology referral revealed LVH + LA enlargement and elevated proBNP and she was diagnosed with diastolic HF. PET scan showed increased uptake in the tongue, likely due to macroglossia. She continued to have decreased glomerular filtration rate consistent with stage IIIb chronic kidney disease. Patient was started on chemotherapy with Dara-CyborD. Two months after her initial presentation, she developed acute watery diarrhea for 2 days, became hypotensive and was admitted to the intensive care unit with septic shock secondary to E. coli bacteremia likely due to translocation. Patient was discharged in stable condition after treatment with IV antibiotics. She is currently doing well and has resumed her chemotherapy regimen cycles. Discussion: Ours was a case of a localized jejunal ulcer as the first manifestation of systemic amyloidosis with cardiac, renal and gastrointestinal (GI) involvement. While Cowen et al estimates that GI involvement is seen in 3%-8% of amyloidosis patients, jejunal involvement remains exceptionally rare with only a few documented cases in literature. We also hypothesized that her large hiatal hernia may have been the result of amyloid fibril deposition in the smooth muscle of the gastric wall leading to structural weakening. Our case also shows the benefit of collecting biopsies from multiple GI sites as jejunal biopsy enabled us to have an earlier diagnosis of amyloidosis and start curative treatment timely.

The American Journal of GastroenterologyVol. 120(10S2)
Good health and well-being
Openalex Percentile: Top 41%
Amyloidosis: Diagnosis, Treatment, Outcomes
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.